Anghad, Daisy May A.
HRN: 26-01-66 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/07/2024
CEFUROXIME 750MG (VIAL)
10/07/2024
10/14/2024
IV
750
Q8h
PCAP C
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes